OneSource Specialty Pharma Ltd. ಕಂಪನಿ ಇತಿಹಾಸ ಮತ್ತು ವಾರ್ಷಿಕ ಬೆಳವಣಿಗೆ ವಿವರ

Our Company was incorporated as a private limited company under the Companies Act, 1956, with the name and style of ‘Inbiopro Solutions Private Limited’ and a certificate of incorporation dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore. The name of our Company was then changed to ‘Stelis Biopharma Private Limited’, pursuant to a scheme of amalgamation and a certificate of incorporation pursuant to change of name dated December 24, 2014, was issued by the Registrar of Companies, Karnataka at Bangalore. Our Company was then converted from a private limited company to a public company on July 31, 2021, and consequently renamed as ‘Stelis Biopharma Limited’ and a fresh certificate of incorporation dated July 31, 2021, was issued by the Registrar of Companies, Karnataka at Bangalore. Subsequently, the name of our Company was changed to its present name ‘Onesource Specialty Pharma Limited’ on February 13, 2024, and a fresh certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

Major Events and Milestones:

2007

- Our Company was incorporated under the name and style of ‘Inbiopro Solutions Private Limited’

2014

- The name of our Company was changed to ‘Stelis Biopharma Private Limited’

2021

- Our Company was converted from a private limited company to a public limited company and consequently renamed as ‘Stelis Biopharma Limited’

2024

- The name of our Company was changed to ‘Onesource Specialty Pharma Limited’

- Demerger, transfer and vesting of the Demerged Undertaking from Strides and Steriscience into our Company on a going concern basis pursuant to the Scheme of Arrangement

2025

-OneSource Specialty Pharma Limited and Sweden-based biotechnology firm Xbrane Biopharma AB (listed on Nasdaq under the ticker XBRANE), have announced a strategic partnership for the commercial manufacturing of Xbrane’s biosimilar portfolio for global markets.

-OneSource Specialty Pharma Limited has received a "Voluntary Action Indicated" (VAI) classification from
the U.S. Food and Drug Administration (USFDA), confirming its continued compliance.